tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
BUX
BioMark Diagnostics
RESEARCH TOOLSreports
Want to see TSE:BUX full AI Analyst Report?

BioMark Diagnostics (BUX) Financial Statements

3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently C$57.80M. The company's EPS TTM is C$-0.0172; its P/E ratio is -34.01; BioMark Diagnostics is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 22Jun 21Mar 20
Income Statement
Total RevenueC$ 154.22KC$ 163.22KC$ 153.49KC$ 0.00C$ 263.28K
Gross ProfitC$ 154.22KC$ 163.22KC$ -232.70KC$ -13.69KC$ 263.28K
Operating IncomeC$ -1.91MC$ -1.32MC$ -1.84MC$ -1.09MC$ -1.18M
EBITDAC$ -1.46MC$ -919.05KC$ -1.35MC$ -1.08MC$ -1.20M
Net IncomeC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09MC$ -1.22M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.48MC$ 156.75KC$ 72.04KC$ 877.68KC$ 611.80K
Total AssetsC$ 3.13MC$ 1.09MC$ 732.29KC$ 952.94KC$ 637.29K
Total DebtC$ 454.16KC$ 1.55MC$ 823.87KC$ 119.32KC$ 8.66K
Net DebtC$ -2.03MC$ 1.39MC$ 751.83KC$ -758.35KC$ -603.14K
Total LiabilitiesC$ 1.39MC$ 1.70MC$ 1.88MC$ 1.03MC$ 1.08M
Stockholders' EquityC$ 1.74MC$ -609.61KC$ -1.15MC$ -79.09KC$ -439.13K
Cash Flow
Free Cash FlowC$ -1.10MC$ -986.91KC$ -919.72KC$ -455.55KC$ -454.57K
Operating Cash FlowC$ -1.09MC$ -982.52KC$ -914.42KC$ -455.55KC$ -453.79K
Investing Cash FlowC$ -3.53KC$ -4.39KC$ -5.30KC$ -3.20KC$ -790.00
Financing Cash FlowC$ 3.42MC$ 1.07MC$ 609.05KC$ 724.63KC$ 1.05M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

Income Statement >

BioMark Diagnostics Debt to Assets

Balance Sheet >

BioMark Diagnostics Cash Flow

Cash Flow >

BioMark Diagnostics Forecast EPS vs Actual EPS

Earnings >